CS
ARTL icon

Clear Street’s Artelo Biosciences ARTL Stock Holding History

Clear Street’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$758 Buy
+100
New +$473 ﹤0.01% 1052

Other funds holding ARTL

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.62B AUM 17.7% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Clear Street's ARTL Position: Q1 2026 in Review

Clear Street opened a new position in Artelo Biosciences (ARTL) in Q1 2026: 100 shares worth $758. The stake represents ﹤0.01% of the portfolio and ranks #1052 among its holdings.

11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

  • Clear Street held 100 shares of Artelo Biosciences worth $758 as of Q1 2026.
  • Artelo Biosciences was a new Clear Street position in Q1 2026.
  • Artelo Biosciences made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #1052 holding.
  • 11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.